Trinity Pharma Raises $15M in Series A Funding

trinityTrinity Pharma, a Boston, MA-based provider of cloud-based data, analytics and mobile solutions for the global life sciences industry, raised $15M in Series A funding.

The round was led by Health Enterprise Partners (HEP). In conjunction with the funding, David Tamburri, HEP General Partner, joined Trinity’s board.

The company intends to use the funds to to expand its sales and delivery teams and to continue to advance its core product, AgileM.

Co-Founded by CEO Zackary King and John Corcoran, Chairman, Trinity Pharma provides AgileM, a cloud-based, HTML5 mobile analytics platform for life sciences companies to access insight from the massive amounts of commercial health data within their organizations to improve tactical and strategic decision making across sales and marketing teams.



Join the discussion